Lantheus Holdings, Inc. (FRA:0L8)

Germany · Delayed Price · Currency is EUR

56.66

+0.28 (0.50%)

At close: Jan 23, 2026

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
PYLARIFY Revenue	1.01B	1.06B
Other Radiopharmaceutical Oncology Revenue	-	384.00K
Total Radiopharmaceutical Oncology Revenue	1.01B	1.06B
DEFINITY Revenue	331.10M	317.79M
TechneLite Revenue	90.93M	95.49M
Other Precision Diagnostics Revenue	24.86M	24.23M
Total Precision Diagnostics Revenue	467.33M	437.51M
Strategic Partnerships and Other Revenue	43.74M	38.18M
Revenue (Total)	1.53B	1.53B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Product Revenue	1.51B	1.52B
License and Royalty Revenue	19.67M	9.13M
Revenue (Total)	1.53B	1.53B

Updated Sep 30, 2025. Data Source: Fiscal.ai.